These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20811626)

  • 1. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.
    Hildebrandt MA; Komaki R; Liao Z; Gu J; Chang JY; Ye Y; Lu C; Stewart DJ; Minna JD; Roth JA; Lippman SM; Cox JD; Hong WK; Spitz MR; Wu X
    PLoS One; 2010 Aug; 5(8):e12402. PubMed ID: 20811626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
    Wen J; Liu H; Wang Q; Liu Z; Li Y; Xiong H; Xu T; Li P; Wang LE; Gomez DR; Mohan R; Komaki R; Liao Z; Wei Q
    Eur J Cancer; 2014 Jul; 50(10):1706-1716. PubMed ID: 24780874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Li R; Pu X; Chang JY; Ye Y; Komaki R; Minna JD; Roth JA; Han B; Wu X
    PLoS One; 2016; 11(3):e0150467. PubMed ID: 26991123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.
    Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Hahn S; Liao Z
    Oncotarget; 2017 Jun; 8(26):43080-43090. PubMed ID: 28574846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.
    Wen J; Liu H; Wang L; Wang X; Gu N; Liu Z; Xu T; Gomez DR; Komaki R; Liao Z; Wei Q
    J Thorac Oncol; 2018 May; 13(5):660-675. PubMed ID: 29454863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
    Yin M; Liao Z; Liu Z; Wang LE; Gomez D; Komaki R; Wei Q
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e67-73. PubMed ID: 21420246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.
    Yuan X; Liao Z; Liu Z; Wang LE; Tucker SL; Mao L; Wang XS; Martel M; Komaki R; Cox JD; Milas L; Wei Q
    J Clin Oncol; 2009 Jul; 27(20):3370-8. PubMed ID: 19380441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer.
    Pu X; Wang L; Chang JY; Hildebrandt MA; Ye Y; Lu C; Skinner HD; Niu N; Jenkins GD; Komaki R; Minna JD; Roth JA; Weinshilboum RM; Wu X
    Clin Pharmacol Ther; 2014 Nov; 96(5):609-15. PubMed ID: 25054431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy.
    Yin M; Liao Z; Yuan X; Guan X; O'Reilly MS; Welsh J; Wang LE; Wei Q
    Cancer Sci; 2012 May; 103(5):945-50. PubMed ID: 22320189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
    Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.
    Yin M; Liao Z; Huang YJ; Liu Z; Yuan X; Gomez D; Wang LE; Wei Q
    PLoS One; 2011; 6(5):e20055. PubMed ID: 21647442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
    Xiong H; Liao Z; Liu Z; Xu T; Wang Q; Liu H; Komaki R; Gomez D; Wang LE; Wei Q
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1066-73. PubMed ID: 23154078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.
    Tucker SL; Li M; Xu T; Gomez D; Yuan X; Yu J; Liu Z; Yin M; Guan X; Wang LE; Wei Q; Mohan R; Vinogradskiy Y; Martel M; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):251-7. PubMed ID: 22541966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.
    Yin M; Liao Z; Liu Z; Wang LE; O'Reilly M; Gomez D; Li M; Komaki R; Wei Q
    Cancer; 2012 Jan; 118(2):528-35. PubMed ID: 21717429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of SP-D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy.
    Xu L; Jiang J; Li Y; Zhang L; Li Z; Xian J; Jiang C; Diao Y; Su X; Xu H; Zhang Y; Zhang T; Yang Z; Tan B; Li H
    Cancer Med; 2019 May; 8(5):2599-2611. PubMed ID: 30897289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM polymorphisms are associated with risk of radiation-induced pneumonitis.
    Zhang L; Yang M; Bi N; Fang M; Sun T; Ji W; Tan W; Zhao L; Yu D; Lin D; Wang L
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1360-8. PubMed ID: 20171797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study.
    Haslett K; Bayman N; Franks K; Groom N; Harden SV; Harris C; Hanna G; Harrow S; Hatton M; McCloskey P; McDonald F; Ryder WD; Faivre-Finn C
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1341-1348. PubMed ID: 33232772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
    Rosenman JG; Halle JS; Socinski MA; Deschesne K; Moore DT; Johnson H; Fraser R; Morris DE
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):348-56. PubMed ID: 12243807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of treatment breaks and radiation-induced esophagitis and pneumonitis using amifostine in unresectable non-small cell lung cancer patients receiving definitive concurrent chemotherapy and radiation therapy: a prospective community-based clinical trial.
    Wynn RB; Mehta V
    Semin Oncol; 2005 Apr; 32(2 Suppl 3):S99-104. PubMed ID: 16015543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.
    Antonadou D; Petridis A; Synodinou M; Throuvalas N; Bolanos N; Veslemes M; Sagriotis A
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):2-9. PubMed ID: 14727235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.